Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,011 total articles
Trio-Tech International supplies burn-in and reliability test equipment for semiconductors and industrial electronics. Recent share-price strength, improving technicals and a compact float create an asymmetric opportunity if AI-driven demand for reliable chips translates to equipment orders. Trade plan: go long at $13.50, stop $11.50, target $19.00…
GoPro is a deeply speculative, event-driven opportunity. With a market cap around $127M and a strategic review underway (Houlihan Lokey retained on 05/15/2026), the stock can gap sharply on a sale or strategic tie-up. Fundamentals remain weak, but the takeover path is the catalyst. This trade is for nimble, risk-tolerant traders prepared for binary…
Booz Allen (BAH) looks oversold after a sharp pullback to the low $60s. The company boasts $951M in free cash flow, a sub-10x P/E, and dividend yield north of 3.5%. With Pentagon reallocation to AI and space programs driving contract opportunities, a long position sized conservatively can capture a recovery while dividend income cushions downside.
Accenture's stock is trading near multi-year lows after a weak revenue outlook and macro pressure. The business still throws off strong free cash flow, carries modest debt, and sits on one of the more attractive yields in its peer set. This trade idea frames a long trade into the exhaustion low with a clear entry, stop and target and explains the f…
Microsoft's Azure and enterprise AI stack are uniquely positioned to monetize large-scale industrial AI contracts like the Chevron arrangement. With Azure growth still healthy, a fortress balance sheet, and attractive free cash flow, MSFT looks due for a re-rating if energy and industrial customers convert pilots into multiyear cloud commitments.
Albemarle (ALB) is highly levered to lithium economics. If lithium spot pricing re-prices toward a $20 reference point, Albemarle's cash flow and multiple will compress quickly. Given the stock's current technical setup, negative EPS, and modest leverage, a tactical short with defined risk/reward looks attractive over a 180-trading-day horizon.
Blue Owl's stock has been sold off alongside broader private-credit anxiety and litigation chatter. The business generates meaningful free cash flow, trades at a double-digit FCF yield versus peers, and pays a substantial quarterly distribution. This trade idea buys the pullback with a tight stop near the 52-week low and a mid-term target that refl…
Synopsys just reset its revenue and earnings mix through the Ansys play and stands to benefit as engineering workflows adopt AI agents. The market is skeptical today — shares fell after a beat — which creates a controlled risk entry. This trade targets a re-rating toward analyst consensus near $538 over the next 180 trading days, with a stop at $43…
JinkoSolar (JKS) trades at roughly $870M market cap, a price-to-book of 0.38 and a $1.48 annual distribution that yields ~7.4%. Recent headlines - a $214.5M GAAP loss tied to a non-cash impairment and regulatory scrutiny - have created a high fear premium. Fundamentals of global solar demand and wafer/bifacial growth argue for recovery. Trade plan:…
Taiwan Semiconductor (TSM) sits at the center of the AI infrastructure build-out. With a dominant share of the most advanced nodes, improving technical setup, and a market cap of roughly $2.26 trillion, TSM offers a tradeable long on a mid-term horizon. This idea lays out a clear entry at $437.25, a stop at $405.00, and a target at $480.00 over the…
CGI trades at a mid-teens discount to large peers on a trailing PE near 11 and is sitting close to its 52-week low. The combination of targeted tuck-in M&A, partnerships in payments/authentication and structural growth in telecom expense management and automation give the stock a reasonable chance to outperform over the next 180 trading days - prov…
Fate Therapeutics' FT819 off-the-shelf CAR T data and operational progress have re‑energized sentiment. With shares near $2.17, a $3.00 target offers meaningful upside vs. a disciplined $1.65 stop. This is a high-risk, event-driven swing trade sized for patient, risk-aware traders.
<p>McEwen is executing a capital-light growth plan: incoming cash from San José plus near-term project starts and a strong pre-feasibility at Grey Fox position the company to reach 250k-300k gold equivalent ounces (GEOs) by 2030 without meaningful dilution. At $18.12 and a $1.08B market cap the shares trade at reasonable multiples against improving…
Hammond Power Solutions sits squarely in the middle of multi-year demand drivers for distribution and specialty transformers. The stock trades at a premium, but the premium is justified by durable backlog, margin resilience and a shortage-sensitive market. We recommend a long trade sized to risk appetite with a $26.50 entry, $34.00 target and $21.5…
SpaceX remains the private crown jewel of commercial aerospace. While public financials are limited, the company's unique asset mix - reusable rockets, the Starlink constellation and fast-growing government & commercial launch backlog - creates asymmetric upside in a public market. I recommend a speculative long around $85.00 with a $62.00 stop and…
Veeva's life-sciences cloud franchise is showing early, measurable benefits from AI-enabled workflow automation. Recent results and partner integrations make the AI monetization path more credible, while valuation and technicals create a manageable entry for a swing trade. This idea outlines a clear entry, stop and target with a 45-trading-day hori…
Ørsted has the portfolio and backlog to benefit from a multiyear offshore wind build cycle. Near-term macro noise and execution uncertainty keep sentiment muted, but the path to clearer cashflows via project completions and operating leverage argues for a tactical long. This trade aims to capture mid-term re-rating as projects move into operations …
Valaris ($78.54) offers a two-legged opportunity: a near-term merger-arbitrage trade to capture a likely spread tightening and a longer-term asymmetric payoff if the Transocean all-stock acquisition closes and the combined company achieves targeted cost synergies and backlog growth. Entry at $78.50 with disciplined risk control balances a modest ar…
Gatekeeper Systems appears to be shifting from promise to performance. Early operational wins, management commentary and a cleaner balance-sheet narrative justify a long trade with tight risk control and a time-bound horizon. This is a tactical idea: size it carefully and treat as a proof-of-concept bet that management can convert bookings into rep…
Sandisk (SNDK) has ripped higher over the past year but today’s pullback offers a disciplined entry into a secular winner in NAND flash. The company combines high free cash flow, strong returns on capital and direct exposure to AI data-center demand. Valuation is rich, so position size and a tight stop are essential. Trade plan: enter $2,030.00, st…
Conexeu (CNXU) is a small regenerative biomaterials company trading at $10.55 with a $282M market cap. With issued patents, a platform product (CXU) and plans for a 510(k) submission in early 2027, the stock is an event-driven long. Enter at $10.55, target $16.00 and stop $8.00 for a long-term trade tied to the regulatory runway and commercializati…
StoneX has rallied hard into its 52-week high on solid business wins and expanding payments/commodities capabilities. Fundamentals look healthy - free cash flow of $5.55B and ROE ~16.6% - but momentum indicators are extended and the share price now discounts a lot of near-term upside. We downgrade to Hold and lay out an actionable plan to lock gain…
Lululemon is trading like a broken growth story in North America while international demand - notably China - still prints robust numbers. The stock's P/E near 8.5 and EV/EBITDA ~4.2 price in a lot of downside. This trade idea targets a mid-term rebound driven by improving international comps, a cheap valuation floor, and a sharply oversold technic…
agilon Health (AGL) looks like a classic post-restructuring growth replay: Q1 operational improvement, a new CEO with payer/ops credibility, and a dramatic stock rerate off a $7.48 low to near $120. The fundamentals still carry legacy drag (negative EPS, negative FCF), but valuation is affordable on revenue multiples and the legal overhang is mostl…
PDD Holdings trades at a forward P/E near 8x after a painful derating. Underneath the headline slowdown are stabilizing metrics: $15.3B operating cash flow in 2025, ongoing supply-chain investments that should improve merchant economics, and an oversold setup (RSI ~28). This is a tactical long for traders willing to take a mid-term view while prote…
